Weight loss medication for teens and young adults after leukemia or lymphoma treatment
Part of Cancer, Hormones & metabolism clinical trials.
This study tests a combination pill (phentermine and topiramate) to help teens and young adults who are overweight after finishing treatment for certain blood cancers. The goal is to see if it helps with weight loss and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 24 years old
- You have had acute lymphoblastic leukemia, Hodgkin lymphoma, or non-Hodgkin lymphoma
- You have finished or are finishing your main treatment and are in remission
- You are overweight or obese (BMI at or above the 95th percentile for your age and sex, or BMI of 30 or higher)
- You are not currently taking other weight-loss medications or stimulants
- You are not pregnant or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different smartphone-based programs to help young adult cancer survivors lose weight. Participants are randomly assigned to one of two programs and use an app to track their progress.
This trial tests if combining resistance exercise with the weight-loss medication tirzepatide can improve heart and metabolic health in survivors of childhood acute lymphoblastic leukemia (ALL) who are now adults and have obesity or overweight with related health issues. You may benefit if you finished treatment at least 2 years ago and meet weight and health criteria.
This study tests a medicine called phentermine to help teens ages 12 to 17 with obesity lose weight. It will check if the medicine is safe and works well for teenagers.
This study helps childhood leukemia survivors avoid unhealthy weight gain during and after maintenance chemotherapy. It uses family-based counseling and exercise to promote healthy habits.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
This trial tests a bilingual, online program to help children and teens who have ALL (a type of leukemia) stay at a healthy weight during the maintenance phase of treatment. It may help lower the chance of gaining too much weight while on chemotherapy.
Hear when a new Acute Lymphoblastic Leukemia in Remission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.